MRI‐Based Deep‐Learning Model for Distant Metastasis‐Free Survival in Locoregionally Advanced Nasopharyngeal Carcinoma
Lu Zhang,Xiangjun Wu,Jing Liu,Bin Zhang,Xiaokai Mo,Qiuying Chen,Jin Fang,Fei Wang,Minmin Li,Zhuozhi Chen,Shuyi Liu,Luyan Chen,Jingjing You,Zhe Jin,Binghang Tang,Di Dong,Shuixing Zhang
DOI: https://doi.org/10.1002/jmri.27308
IF: 4.4
2020-08-09
Journal of Magnetic Resonance Imaging
Abstract:<section class="article-section__content"><h3 class="article-section__sub-title section1"> Background</h3><p>Distant metastasis is the primary cause of treatment failure in locoregionally advanced nasopharyngeal carcinoma (LANPC).</p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Purpose</h3><p>To develop a model to evaluate distant metastasis‐free survival (DMFS) in LANPC and to explore the value of additional chemotherapy to concurrent chemoradiotherapy (CCRT) for different risk groups.</p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Study Type</h3><p>Retrospective.</p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Population</h3><p>In all, 233 patients with biopsy‐confirmed nasopharyngeal carcinoma (NPC) from two hospitals.</p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Field Strength</h3><p>1.5T and 3T.</p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Sequence</h3><p>Axial T<sub>2</sub>‐weighted (T<sub>2</sub>‐w) and contrast‐enhanced T<sub>1</sub>‐weighted (CET<sub>1</sub>‐w) images. </p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Assessment</h3><p>Deep learning was used to build a model based on MRI images (including axial T<sub>2</sub>‐w and CET<sub>1</sub>‐w images) and clinical variables. Hospital 1 patients were randomly divided into training (<i>n = </i> 169) and validation (<i>n = </i> 19) cohorts; Hospital 2 patients were assigned to a testing cohort (<i>n = </i> 45). LANPC patients were divided into low‐ and high‐risk groups according to their DMFS (<i>P </i> < 0.05). Kaplan–Meier survival analysis was performed to compare the DMFS of different risk groups and subgroup analysis was performed to compare patients treated with CCRT alone and treated with additional chemotherapy to CCRT in different risk groups, respectively. </p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Statistical Tests</h3><p>Univariate analysis was performed to identify significant clinical variables. The area under the receiver operating characteristic (ROC) curve (AUC) was used to assess the model performance.</p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Results</h3><p>Our deep‐learning model integrating the deep‐learning signature, node (N) stage (from TNM staging), plasma Epstein–Barr virus (EBV)‐DNA, and treatment regimens yielded an AUC of 0.796 (95% confidence interval [CI]: 0.729–0.863), 0.795 (95% CI: 0.540–1.000), and 0.808 (95% CI: 0.654–0.962) in the training, internal validation, and external testing cohorts, respectively. Low‐risk patients treated with CCRT alone had longer DMFS than patients treated with additional chemotherapy to CCRT (<i>P </i> < 0.05). </p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Data Conclusion</h3><p>The proposed deep‐learning model, based on MRI features and clinical variates, facilitated the prediction of DMFS in LANPC patients.</p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Level of Evidence</h3><p>3.</p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Technical Efficacy Stage</h3><p>4.</p></section>
radiology, nuclear medicine & medical imaging